UnitedHealthcare To End Certain Home Health Prior Authorization Requirements As Part Of Larger Push

UnitedHealthcare is eliminating prior authorization requirements for certain home health services provided under Medicare Advantage plans as part of a larger push to cut prior authorization volume by 10% this year. Effective April 1, 2025, the insurance giant—part of UnitedHealth Group (NYSE: UHG)—will no longer require prior authorization or concurrent review processes for home health […]

Amedisys Reports Home Health Care Growth Amid Shadow Of DOJ-UHG Lawsuit

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending acquisition by UnitedHealth Group (NYSE: UNH). The company’s home health business reported net service revenues of $377 million for the fourth quarter of 2024, an increase from $358.9 million in the same quarter […]

With Amedisys Case Ongoing, DOJ Reportedly Also Investigating UHG’s Medicare Advantage Billing

Amid the U.S. Department of Justice’s (DOJ) legal battle with UnitedHealth Group (NYSE: UHG) regarding the planned purchase of Amedisys (Nasdaq: AMED), the company is also now reportedly facing an investigation for a different matter. The DOJ is currently pursuing a civil fraud investigation focused on the company’s practices for recording diagnoses that activate extra […]

Inside UnitedHealth Group’s Defense Of $3.3B Amedisys Acquisition

Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the case closer to trial and shed more light on how UnitedHealth and Amedisys are pursuing divestments and defending the transaction. First, UnitedHealth dropped its motion to dismiss the case, saying that the […]

UnitedHealth Group Drops Motion To Dismiss DOJ’s Amedisys Antitrust Lawsuit

UnitedHealth Group Inc. (NYSE: UNH) is dropping its motion to dismiss the U.S. Department of Justice’s (DOJ) antitrust lawsuit regarding the company’s plans to acquire home-based care giant Amedisys in a $3.3 billion deal. UnitedHealth Group is one of the largest companies in the country and has an array of associated business lines. Should the […]

Fewer Medicare Advantage Plans Are Offering Home-Based Care Services For 2025

Last year, many major Medicare Advantage (MA) organizations released previews of what benefits they planned to offer seniors this year. Many of these organizations have moved away from offering plans that include home-based care services. In fact, ATI Advisory found that fewer MA plans were offering benefits, such as in-home services and support, as well […]

Top Home Health Trends For 2025

The year ahead will be a fascinating one in home health care. As 2025 dawns, the industry faces many uncertainties, and the next 12 months will be pivotal in shaping the future. Regulatory decisions will have an outsized impact on home health providers in the near-term, and their effects could stretch well into the future. […]

VitalCaring Deal Reportedly Suspended As UnitedHealth, Amedisys Seek Path Forward

Amedisys’ (Nasdaq: AMED) planned divestiture of more than 100 home health and hospice locations to VitalCaring has reportedly been halted following a federal court ruling that requires Texas-based VitalCaring to allocate a significant portion of its future profits to Encompass Health and Enhabit. Amedisys in June announced an agreement to sell some of its locations […]

Inside the Future Of Contessa Health And High-Acuity Care at Home 

When Amedisys Inc. (Nasdaq: AMED) acquired Contessa Health for $250 million in 2021, it changed the home-based care landscape. While other companies had been toying with high-acuity care in the home, that deal sent a clear message: Home-based care was becoming more than just Medicare-certified home health care and personal care services. Since that point, […]